Single-nucleotide polymorphisms (5p15.33, 15q25.1, 6p22.1, 6q27 and 7p15.3) and lung cancer survival in the European Prospective Investigation into Cancer and Nutrition (EPIC)

Mutagenesis

Volumn 26, Issue 5, 2011, Pages 657-666

  Xun, Wei Wei ^a   Brennan, Paul ^b   Tjonneland, Anne ^c   Vogel, Ulla ^d   Overvad, Kim ^e   Kaaks, Rudolf ^f   Canzian, Federico ^f   Boeing, Heiner ^g   Trichopoulou, Antonia ^h   Oustoglou, Erifili ^h   Giotaki, Zoi ^h   Johansson, Mattias ^b   Palli, Domenico ⁱ   Agnoli, Claudia ^j   Tumino, Rosario ^k   Sacerdote, Carlotta ^l   Panico, Salvatore ^m   Bueno De Mesquita, H Bas ⁿ   Peeters, Petra H M ^o   Lund, Eiliv ^p   Kumle, Merethe ^p   Rodríguez, Laudina ^q   Agudo, Antonio ^r   Sánchez, Maria José ^s,t   Arriola, Larraitz ^u   Chirlaque, María Dolores ^t   Barricarte, Aurelio ^t,v   Hallmans, Göran ^w   Rasmuson, Torgny ^x   Khaw, Kay Tee ^y   Wareham, Nicholas ^z   Key, Tim ^aa   Riboli, Elio ^a   Vineis, Paolo ^a   more..

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^h UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

ⁱ CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^j NATIONAL CANCER INSTITUTE   (Italy)

^k CIVILE M P AREZZO HOSPITAL   (Italy)

^l ISI FOUNDATION   (Italy)

^m UNIVERSITY OF NAPLES FEDERICO II   (Italy)

ⁿ NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^o UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^p UNIVERSITY OF TROMSØ   (Norway)

^q Health and Health Care Services Council   (Spain)

^r CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^s ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^t CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^u CIBERESP   (Spain)

^v INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^w UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^x UMEÅ UNIVERSITY   (Sweden)

^y UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^z ADDENBROOKE S HOSPITAL   (United Kingdom)

^aa UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CAUSE OF DEATH; CAUSE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SURVIVAL TIME;

ADULT; AGED; CHROMOSOMES, HUMAN; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 6; CHROMOSOMES, HUMAN, PAIR 7; EUROPE; FEMALE; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING;

EID: 80052335498     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ger030     Document Type: Review

References (36)

1. Verdecchia, A., Francisci, S., Brenner, H., Gatta, G., Micheli, A., Mangone, L. and Kunkler, I. (2007) EUROCARE-4 Working Group (2007) Recent cancer survival in Europe: A 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol., 8, 784-796.
2. Youlden, D., Cramb, S. and Baade, P. J. (2008) The international epidemiology of lung cancer: Geographical distribution and secular trends. J. Thorac. Oncol., 3, 819-831.
3. Amos, C., Wu, X., Broderick, P. et al. (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet., 40, 616-622.
4. Hung, R. J., McKay, J. D., Gaborieau, V. et al. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature, 452, 633-637.
5. Thorgeirsson, T. E., Geller, F., Sulem, P. et al. (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature, 452, 638-642.
6. Wang, Y., Broderick, P., Webb, E. et al. (2008) Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat. Genet., 40, 1407-1409.
7. McKay, J. D., Hung, R. J., Gaborieau, V. et al. (2008) Lung cancer susceptibility locus at 5p.15.33. Nat. Genet., 40, 1404-1406.
8. Shiraishi, K., Kohno, T., Kunitoh, H. et al. (2009) Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smokingindependent manner in the Japanese. Carcinogenesis, 30, 65-70.
9. Bierut, L. J., Stitzel, J. A., Wang, J. C. et al. (2008) Variants in nicotinic receptors and risk for nicotine dependence. Am. J. Psychiatry., 165, 1163-1171.
10. Etter, J. F., Hoda, J. C., Perroud, N., Munafo, M., Buresi, C., Duret, C., Neidhart, E., Malafosse, A. and Bertrand, D. (2009) Association of genes coding for the alpha-4, alpha-5, beta-2 and beta-3 subunits of nicotinic receptors with cigarette smoking and nicotine dependence. Addict. Behav., 34, 772-775.
11. Grucza, R. A., Wang, J. C., Stitzel, J. A. et al. (2008) A risk allele for nicotine dependence in CHRNA5 is a protective allele for cocaine dependence. Biol. Psychiatry., 64, 922-929.
12. Saccone, N. L., Saccone, S. F., Hinrichs, A. L. et al. (2009) Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am. J. Med. Genet. B Neuropsychiatr. Genet., 150B, 453-466.
13. Sherva, R., Wilhelmsen, K., Pomerleau, C. S., Chasse, S. A., Rice, J. P., Snedecor, S. M., Bierut, L. J., Neuman, R. J. and Pomerleau, O. F. (2008) Association of a single nucleotide polymorphism in neuronal acetylcholine receptor subunit alpha 5 (CHRNA5) with smoking status and with 'pleasurable buzz' during early experimentation with smoking. Addiction, 103, 1544-1552.
14. Zienolddiny, S., Skaug, V., Landvik, N. E., Ryberg, D., Phillips, D. H., Houlston, R. and Haugen, A. (2009) The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. Carcinogenesis, 30, 1368-1371.
15. Yang, P., Li, Y. F., Jiang, R. X., Cunningham, J. M., Zhang, F. and de Andrade, M. (2010) A rigorous and comprehensive validation: Common genetic variations and lung cancer. Cancer Epidemiol. Biomarkers Prev., 19, 240-244.
16. Sreeja, L., Syamala, V., Raveendran, P., Santhi, S., Madhavan, J. and Ankathil, R. ((2008 )) p53 Arg72Pro polymorphism predicts survival outcome in lung cancer patients in Indian population. Cancer Invest., 26, 41-46.
17. Sreeja, L., Syamala, V. S., Syamala, V., Hariharan, S., Raveendran, P., Vijayalekshmi, R., Madhavan, J. and Ankathil, R. (2008) Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J. Cancer Res. Clin. Oncol., 134, 645-652.
18. Yu, D., Zhang, X., Liu, J. et al. (2008) Characterization of functional excision repair cross-complementation group 1 variants and their association with lung cancer risk and prognosis. Clin. Cancer Res., 14, 2878-2886.
19. Slimani, N., Kaaks, R., Ferrari, P. et al. (2002) European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: Rationale, design and population characteristics. Public Health Nutr., 5, 1125-1145.
20. Travis, W., Colby, T. and Corrin, B. (1999) Histological Typing of Lung and Pleural Tumours. 3rd edn. Springer, Berlin, Germany.
21. Schoenfeld, D. A. and Richter, J. R. (1982) Nomograms for calculating the number of patients needed for a clinical-trial with survival as an endpoint. Biometrics, 38, 163-170.
22. Fine, J. P. and Gray, R. J. (1999) A proportional hazards model for the subdistribution of a competing risk. J. Am. Stat. Assoc., 94, 496-509.
23. Catarino, R., Araujo, A., Coelho, A., Gomes, M., Nogueira, A., Lopes, C. and Medeiros, R. M. (2010) Prognostic significance of telomerase polymorphism in non-small cell lung cancer. Clin. Cancer Res., 16, 3706-3712.
24. Gao, H., Wang, Q., Wang, B., Yan, C., Wang, S., Zhu, J., Huang, C. and Fu, S. (2002) [Genescan analysis of non-small cell lung cancer in the long arm of chromosome 6][Abstract]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 19, 14-16.
25. Wilk, J. B., DeStefano, A. L., Joost, O. et al. (2003) Linkage and association with pulmonary function measures on chromosome 6q27 in the Framingham Heart Study. Hum. Mol. Genet., 12, 2745-2751.
26. Bignone, P. A., Lee, K. Y., Liu, Y. et al. (2007) RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer. Oncogene, 26, 683-700.
27. Blons, H., Pallier, K., Le Corre, D. et al. (2008) Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma. BMC Med. Genomics., 1, 25.
28. Paz-Ares, L., Soulieres, D., Melezinek, I., Moecks, J., Keil, L., Mok, T., Rosell, R. and Klughammer, B. (2010) Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: Pooled analysis. J. Cell. Mol. Med., 14, 51-69.
29. Engeland, A., Bjørge, T., Haldorsen, T. and Tretli, S. (1998) Prognosis of patients with lung cancer diagnosed in Norway, 1954-93. Cancer Causes Control, 9, 57-65.
30. Grivaux, M., Zureik, M., Marsal, L. et al. (2009) Five year survival for lung cancer patients managed in general hospitals. Rev. Mal. Respir., 26, 37-44.
31. Twardella, D., Loew, M., Rothenbacher, D., Stegmaier, C., Ziegler, H. and Brenner, H. (2006) The diagnosis of a smoking-related disease is a prominent trigger for smoking cessation in a retrospective cohort study. J. Clin. Epidemiol., 59, 82-89.
32. Videtic, G. M., Stitt, L. W., Dar, A. R., Kocha, W. I., Tomiak, A. T., Truong, P. T., Vincent, M. D. and Yu, E. W. (2003) Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limitedstage small-cell lung cancer is associated with decreased survival. J. Clin. Oncol., 21, 1544-1549.
33. Cardon, L. R. and Palmer, L. J. (2003) Population stratification and spurious allelic association. Lancet, 361, 598-604.
34. Heath, S. C., Gut, I. G., Brennan, P. et al. (2008) Investigation of the fine structure of European populations with applications to disease association studies. Eur. J. Hum. Genet., 16, 1413-1429.
35. Wacholder, S., Rothman, N. and Caporaso, N. (2000) Population stratification in epidemiologic studies of common genetic variants and cancer: Quantification of bias. J. Natl Cancer Inst., 92, 1151-1158.
36. Yu, K., Wang, Z. M., Li, Q. Z., Wacholder, S., Hunter, D. J., Hoover, R. N., Chanock, S. and Thomas, G. (2008) Population Substructure and control selection in genome-wide association studies. PLoS One, 3, :e2551.